The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Brain and other central nervous system tumor statistics, 2021
Open accessAbstract
Brain and other central nervous system (CNS) tumors are among the most fatal cancers and account for substantial morbidity and mortality in the United States. Population‐based data from the Central Brain Tumor Registry of the United States (a combined data set of the National Program of Cancer Registries [NPCR] and Surveillance, Epidemiology, and End Results [SEER] registries), NPCR, National Vital Statistics System and SEER program were analyzed to assess the contemporary burden of malignant and nonmalignant brain and other CNS tumors (hereafter brain) by histology, anatomic site, age, sex, and race/ethnicity. Malignant brain tumor incidence rates declined by 0.8% annually from 2008 to 2017 for all ages combined but increased 0.5% to 0.7% per year among children and adolescents. Malignant brain tumor incidence is highest in males and non‐Hispanic White individuals, whereas the rates for nonmalignant tumors are highest in females and non‐Hispanic Black individuals. Five‐year relative survival for all malignant brain tumors combined increased between 1975 to 1977 and 2009 to 2015 from 23% to 36%, with larger gains among younger age groups. Less improvement among older age groups largely reflects a higher burden of glioblastoma, for which there have been few major advances in prevention, early detection, and treatment the past 4 decades. Specifically, 5‐year glioblastoma survival only increased from 4% to 7% during the same time period. In addition, important survival disparities by race/ethnicity remain for childhood tumors, with the largest Black‐White disparities for diffuse astrocytomas (75% vs 86% for patients diagnosed during 2009‐2015) and embryonal tumors (59% vs 67%). Increased resources for the collection and reporting of timely consistent data are critical for advancing research to elucidate the causes of sex, age, and racial/ethnic differences in brain tumor occurrence, especially for rarer subtypes and among understudied populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Self-citationThe 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Ostrom, Q. T., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab200 · Cited by 2,529
Self-citationOstrom, Q. T., Patil, N., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa200 · Cited by 1,789
Self-citationInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
International Classification of Childhood Cancer, third edition
Steliarova‐Foucher, E., Stiller, C., Lacour, B., & Kaatsch, P. (2005) · Cancer · doi:10.1002/cncr.20910 · Cited by 1,552
International Statistical Classification of Diseases and Related Health Problems (ICD-10)
Schrader, K. (2023) · Angewandte Lymphologie · doi:10.1007/978-3-662-61452-5_49 · Cited by 683
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Ostrom, Q. T., Cote, D. J., Ascha, M., Kruchko, C., & Barnholtz-Sloan, J. S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1789 · Cited by 614
Self-citationSocial Outcomes in the Childhood Cancer Survivor Study Cohort
Gurney, J. G., Krull, K. R., Kadan-Lottick, N., Nicholson, H. S., Nathan, P. C., Zebrack, B., Tersak, J. M., & Ness, K. K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1458 · Cited by 468
Zebrack, B. J., Gurney, J. G., Oeffinger, K., Whitton, J., Packer, R. J., Mertens, A., Turk, N., Castleberry, R., Dreyer, Z., Robison, L. L., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.148 · Cited by 401
Gurney, J. G., Kadan‐Lottick, N. S., Packer, R. J., Neglia, J. P., Sklar, C. A., Punyko, J. A., Stovall, M., Yasui, Y., Nicholson, H. S., Wolden, S., et al. (2003) · Cancer · doi:10.1002/cncr.11095 · Cited by 369
Risk factors for childhood and adult primary brain tumors
Ostrom, Q. T., Fahmideh, M. A., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz123 · Cited by 314
Self-citationIonizing radiation and the risk of brain and central nervous system tumors: a systematic review
Braganza, M. Z., Kitahara, C. M., Berrington de Gonzalez, A., Inskip, P. D., Johnson, K. J., & Rajaraman, P. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos208 · Cited by 303
Wrensch, M., Lee, M., Miike, R., Newman, B., Bargar, G., Davis, R., Wiencke, J., & Neuhaus, J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009154 · Cited by 218
Females have the survival advantage in glioblastoma
Ostrom, Q. T., Rubin, J. B., Lathia, J. D., Berens, M. E., & Barnholtz-Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy002 · Cited by 192
Self-citationLate Effects of Therapy for Pediatric Brain Tumor Survivors
Turner, C. D., Rey-Casserly, C., Liptak, C. C., & Chordas, C. (2009) · Journal of Child Neurology · doi:10.1177/0883073809341709 · Cited by 190
Neurocognitive function after radiotherapy for paediatric brain tumours
Padovani, L., André, N., Constine, L. S., & Muracciole, X. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.182 · Cited by 152
Allergic Conditions and Brain Tumor Risk
Wigertz, A., Lönn, S., Schwartzbaum, J., Hall, P. N., Auvinen, A. P., Christensen, H. C., Johansen, C., Klæboe, L., Salminen, T. M., Schoemaker, M. J., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm203 · Cited by 134
Pediatric Brain Tumors: Descriptive Epidemiology, Risk Factors, and Future Directions
Fahmideh, M. A., & Scheurer, M. E. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1443 · Cited by 133
Glioma incidence and survival variations by county‐level socioeconomic measures
Coté, D. J., Ostrom, Q. T., Gittleman, H. R., Duncan, K. R., CreveCoeur, T. S., Kruchko, C., Smith, T. R., Stampfer, M. J., & Barnholtz‐Sloan, J. S. (2019) · Cancer · doi:10.1002/cncr.32328 · Cited by 127
Self-citationCahill, K. S., & Claus, E. B. (2011) · Journal of neurosurgery · doi:10.3171/2011.3.jns101748 · Cited by 123
Achey, R. L., Gittleman, H. R., Schröer, J., Khanna, V., Kruchko, C., & Barnholtz‐Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy162 · Cited by 107
Self-citationCognitive Risk in Survivors of Pediatric Brain Tumors
Oyefiade, A. A., Paltin, I., Luca, C. R. D., Hardy, K. K., Grosshans, D. R., Chintagumpala, M., Mabbott, D., & Kahalley, L. S. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.02338 · Cited by 106
Understanding inherited genetic risk of adult glioma – a review
Rice, T., Lachance, D. H., Molinaro, A. M., Eckel‐Passow, J. E., Walsh, K. M., Barnholtz‐Sloan, J. S., Ostrom, Q. T., Francis, S. S., Wiemels, J. L., Jenkins, R. B., et al. (2015) · Neuro-Oncology Practice · doi:10.1093/nop/npv026 · Cited by 98
Self-citationFunctioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
Varlamov, E. V., McCartney, S., & Fleseriu, M. (2019) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2019.15.1.30 · Cited by 88
Medical Diagnostic Radiation Exposures and Risk of Gliomas
Davis, F. G., Il’yasova, D., Rankin, K., McCarthy, B. J., & Bigner, D. D. (2011) · Radiation Research · doi:10.1667/rr2186.1 · Cited by 83
Socioeconomic status and glioblastoma risk: a population-based analysis
Porter, A. B., Lachance, D. H., & Johnson, D. R. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0496-x · Cited by 80
Siegel, D. A., Li, J., Ding, H., Singh, S. D., King, J., & Pollack, L. A. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.27501 · Cited by 41
van Schaïk, J., van Roessel, I. M. A. A., Meeteren, N. S.-V., van Iersel, L., Clement, S. C., Boot, A. M., der Grinten, H. L. C., Fiocco, M. F., Janssens, G. O. R. J., van Vuurden, D. G., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01765 · Cited by 30
Pilocytic astrocytoma: Where do they belong in cancer reporting?
Ostrom, Q. T., Kruchko, C., & Barnholtz‐Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz202 · Cited by 23
Self-citationAre Benign and Borderline Brain Tumors Underreported?
Li, X., Kruchko, C., Wu, X., Hsieh, M., Andrews, P. A., Huang, B., Qiao, B., & Wohler, B. (2016) · PubMed · Cited by 22
Self-citationMitchell, H. K., Morris, M., Ellis, L., Abrahão, R., & Bonaventure, A. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.101644 · Cited by 21
Worrell, S. L., Kirschner, M. L., Shatz, R. S., Sengupta, S., & Erickson, M. (2021) · Current Oncology Reports · doi:10.1007/s11912-020-01004-8 · Cited by 18
Cited by
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
Liu, Y., Zhou, F., Ali, H., Lathia, J. D., & Chen, P. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01226-x · Cited by 336
Ranjbarzadeh, R., Caputo, A., Tirkolaee, E. B., Jafarzadeh Ghoushchi, S., & Bendechache, M. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106405 · Cited by 333
Pouyan, A., Ghorbanlo, M., Eslami, M., Jahanshahi, M., Ziaei, E., Salami, A., Mokhtari, K., Shahpasand, K., Farahani, N., Meybodi, T. E., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02267-0 · Cited by 271
Dunkel, I. J., Doz, F., Foreman, N. K., Hargrave, D., Lassaletta, A., André, N., Hansford, J. R., Hassall, T., Eyrich, M., Gururangan, S., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad031 · Cited by 73
Wu, X., Zhang, S., Zhang, Z., He, Z., Xu, Z., Wang, W., Jin, Z., You, J., Guo, Y., Zhang, L., et al. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00670-2 · Cited by 43
Metadata
- Authors
- Miller, K. D., Ostrom, Q. T., Kruchko, C., Patil, N., Tihan, T., Cioffi, G., Fuchs, H. E., Waite, K. A., Jemal, A., Siegel, R. L., & Barnholtz‐Sloan, J. S.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2021-08-24
- Volume
- 71
- Issue
- 5
- Pages
- 381-406
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W3193929510
- Cited by
- 997
- References
- 34
- FWCI
- 75.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.